MARKET

ADMA

ADMA

Adma Biologics
NASDAQ
19.98
-1.22
-5.75%
After Hours: 20.00 +0.02 +0.10% 19:59 05/09 EDT
OPEN
20.72
PREV CLOSE
21.20
HIGH
21.48
LOW
19.86
VOLUME
4.14M
TURNOVER
--
52 WEEK HIGH
25.67
52 WEEK LOW
6.72
MARKET CAP
4.77B
P/E (TTM)
23.78
1D
5D
1M
3M
1Y
5Y
1D
Kymera' s Q1 Loss Narrower Than Expected, Pipeline Progress Encouraging
NASDAQ · 1d ago
Pacira BioSciences Q1 Earnings Beat, Revenues Miss Estimates
NASDAQ · 1d ago
RCKT's Q1 Loss Narrower Than Expected, Pipeline in Focus
NASDAQ · 1d ago
Invesco Main Street Small Cap Fund Q1 2025 Commentary
Seeking Alpha · 1d ago
Biotech Outperformance - Can't Take What's Already Earned
Seeking Alpha · 2d ago
PBYI Stock Rises as Q1 Earnings and Sales Beat Estimates
Barchart · 2d ago
ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss
Seeking Alpha · 2d ago
ADMA Biologics Reports Strong Growth and Strategic Advances
TipRanks · 2d ago
More
About ADMA
More
ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The Company manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: ASCENIV (immune globulin intravenous, human-slra 10% liquid) for the treatment of primary humoral immunodeficiency (PI); BIVIGAM (immune globulin intravenous, human) for the treatment of PI; and NABI-HB (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. Through its ADMA BioCenters subsidiary, the Company also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products.
Recently
Symbol
Price
%Change

Webull offers ADMA Biologics Inc stock information, including NASDAQ: ADMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADMA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADMA stock methods without spending real money on the virtual paper trading platform.